Evofem Biosciences, Inc.
EVFM
Revenue
4.16M
▲557.00k▲15.46%
3 Months ChangeAssets
8.55M
▲334.00k▲4.06%
3 Months ChangeLiabilities
73.18M
▼-1.06M▼-1.43%
3 Months ChangeFree Cash Flow
109.00k
▲5.05M▲102.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001493152-24-043241
2024-10-28
Form 8-K
ID: 0001493152-24-042605
2024-10-03
Form 8-K
ID: 0001493152-24-039392
2024-09-25
Form 8-K
ID: 0001493152-24-038113
2024-09-06
Form 8-K
ID: 0001493152-24-035285
2024-08-30
Form 8-K
ID: 0001493152-24-034623
2024-08-20
Form 8-K
ID: 0001493152-24-033265
2024-08-14
Form 10-Q
ID: 0001493152-24-031846
2024-08-14
Form 8-K
ID: 0001493152-24-031835
2024-07-23
Form 8-K
ID: 0001493152-24-028818